Science Explorer Back to mapMap
Discussion
Researcher · Medscape · United States

John M. Maeglin

John M. Maeglin publishes mostly in Surgery, Oncology and Pathology and Forensic Medicine, on topics such as Colorectal Cancer Screening and Detection, Neurology and Historical Studies and Medicine and Dermatology Studies History.

OpenAlex
World rank
#6,107,817
of 7,710,434 ranked researchers
Rank in United States
#1,476,389
of 1,627,098
Works
24
Citations
1
h-index
1
i10-index 0Top 99.4% in Surgery
John M. Maeglin

What does John M. Maeglin research?

John M. Maeglin's work is mostly in Medicine (30%), Biochemistry, Genetics and Molecular Biology (6%), Neuroscience (4%).

Everything else: 13 works · 54.5% of their workHealth Sciences: 8 works · 34.7% of their workMedicine: 7 works · 30.4% of their workSurgery: 3 works · 13.0% of their workOncology: 3 works · 10.9% of their workPathology and Forensic Medicine: 2 works · 6.5% of their workHealth Professions: 1 works · 4.3% of their workGeneral Health Professions: 1 works · 4.3% of their workLife Sciences: 3 works · 10.8% of their workBiochemistry, Genetics and Molecular Biology: 2 works · 6.5% of their workMolecular Biology: 2 works · 6.5% of their workNeuroscience: 1 works · 4.3% of their workNeurology: 1 works · 4.3% of their workTHEIR WORKJohn M. Maeglin24works
Life Sciences11%Health Sciences35%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else1354.5%
    1. Medicine730.4%
    2. Health Professions14.3%
    1. Biochemistry, Genetics and Molecular Biology26.5%
    2. Neuroscience14.3%
  1. 1Surgery13% of their works
  2. 2Oncology11% of their works
  3. 3Pathology and Forensic Medicine6% of their works
  4. 4Molecular Biology6% of their works
  5. 5General Health Professions4% of their works
  6. 6Neurology4% of their works

Research topics

Which keywords describe John M. Maeglin's research?

The keywords of their largest research topics: Guidelines, Epidemiology, Treatment, Colorectal Cancer, Screening, Clinical Reasoning, Diagnosis and Diagnostic Error.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Guidelines52 topics
  2. Epidemiology42 topics
  3. Treatment42 topics
  4. Colorectal Cancer31 topic
  5. Screening31 topic
  6. Clinical Reasoning21 topic
  7. Diagnosis21 topic
  8. Diagnostic Error21 topic
  9. Eosinophilic Esophagitis21 topic
  10. Hyperuricemia21 topic
  11. Inflammatory Disease21 topic
  12. Prurigo Pigmentosa21 topic
  13. Uric Acid21 topic
  14. neurological history21 topic
  15. neuroscience pioneers21 topic
  16. Epitope Prediction11 topic
  17. Peptide-MHC Binding11 topic
  18. RNA methylation11 topic
  19. m6A-seq11 topic

Where does John M. Maeglin work?

John M. Maeglin's main affiliation in the publication record is Medscape, United States.

How many publications and citations does John M. Maeglin have?

OpenAlex counts 24 works and 1 citations for John M. Maeglin, an h-index of 1, ranking #6,107,817 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about John M. Maeglin. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.